Synairgen (SNG) Competitors GBX 0.82 -0.01 (-1.67%) As of 11:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock SNG vs. COS, C4XD, DDDD, OKYO, AOR, OPTI, AREC, SAR, POLB, and IMMShould you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), OKYO Pharma (OKYO), AorTech International (AOR), OptiBiotix Health (OPTI), Arecor Therapeutics (AREC), Sareum (SAR), Poolbeg Pharma (POLB), and ImmuPharma (IMM). These companies are all part of the "biotechnology" industry. Synairgen vs. Collagen Solutions plc (COS.L) C4X Discovery 4D pharma OKYO Pharma AorTech International OptiBiotix Health Arecor Therapeutics Sareum Poolbeg Pharma ImmuPharma Synairgen (LON:SNG) and Collagen Solutions plc (COS.L) (LON:COS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings, dividends and community ranking. Does the MarketBeat Community believe in SNG or COS? Synairgen received 24 more outperform votes than Collagen Solutions plc (COS.L) when rated by MarketBeat users. However, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 56.46% of users gave Synairgen an outperform vote. CompanyUnderperformOutperformSynairgenOutperform Votes15356.46% Underperform Votes11843.54% Collagen Solutions plc (COS.L)Outperform Votes12972.88% Underperform Votes4827.12% Which has higher valuation & earnings, SNG or COS? Collagen Solutions plc (COS.L) has higher revenue and earnings than Synairgen. Synairgen is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynairgenN/AN/A-£15.86M-£1.66-0.50Collagen Solutions plc (COS.L)£4.01M0.00N/A-£0.80N/A Does the media refer more to SNG or COS? In the previous week, Synairgen's average media sentiment score of 0.00 equaled Collagen Solutions plc (COS.L)'saverage media sentiment score. Company Overall Sentiment Synairgen Neutral Collagen Solutions plc (COS.L) Neutral Do institutionals and insiders believe in SNG or COS? 30.7% of Synairgen shares are held by institutional investors. 3.2% of Synairgen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is SNG or COS more profitable? Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Synairgen's return on equity.Company Net Margins Return on Equity Return on Assets SynairgenN/A -29.40% -30.58% Collagen Solutions plc (COS.L) N/A N/A N/A SummaryCollagen Solutions plc (COS.L) beats Synairgen on 5 of the 9 factors compared between the two stocks. Remove Ads Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNG vs. The Competition Export to ExcelMetricSynairgenBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£8.06M£108.24M£5.64B£2.56BDividend Yield1.53%3.78%5.34%4.95%P/E Ratio-0.503.1023.63138.55Price / SalesN/A4,104.44370.09277,004.67Price / Cash1.9012.7538.1727.96Price / Book0.1735.866.744.51Net Income-£15.86M-£91.48M£3.20B£5.77B7 Day Performance-11.40%-4.09%-5.63%-0.62%1 Month Performance-55.00%57.53%-0.38%5.13%1 Year Performance-83.83%81.51%7.72%31.04% Synairgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGSynairgenN/AGBX 0.82-1.7%N/A-83.6%£8.06MN/A-0.5034Gap DownHigh Trading VolumeCOSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718,000.00-1.08106OKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007Gap DownAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383OPTIOptiBiotix HealthN/AGBX 19+10.1%N/A-17.6%£18.61M£590,009.23-6.011High Trading VolumeARECArecor TherapeuticsN/AGBX 48.25-2.5%N/A-69.8%£18.22M£6.04M-1.7110Gap UpSARSareumN/AGBX 12.42-0.6%N/A+25.0%£15.52MN/A-2.943,211Earnings ReportPositive NewsHigh Trading VolumePOLBPoolbeg PharmaN/AGBX 2.86+0.2%N/A-72.5%£14.67MN/A0.0012IMMImmuPharmaN/AGBX 3.24-9.0%N/A+36.5%£13.77M£-71,310.29-5.6013Gap Down Remove Ads Related Companies and Tools Related Companies Collagen Solutions plc (COS.L) Competitors C4X Discovery Competitors 4D pharma Competitors OKYO Pharma Competitors AorTech International Competitors OptiBiotix Health Competitors Arecor Therapeutics Competitors Sareum Competitors Poolbeg Pharma Competitors ImmuPharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SNG) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
